Infective disease Flashcards
Gram Positive cocc
staPhylococci + strePtococci (including enterococci)
Gram Negative cocci
Neisseria meningitidis + Neisseria gonorrhoeae, also Moraxella
Gram positive rods (bacilli)
- Actinomyces
- Bacillus antracis (anthrax)
- Clostridium
- Diphtheria: Corynebacterium diphtheriae
- Listeria monocytogenes
Antibiotics with anti-anaerobic activity
Penicillins
* Cephalosporins (except ceftazidime)
* Erythromycin
* Metronidazole
* Tetracycline
Antibiotics with NO anti-anaerobic activity
- Gentamicin
- Ciprofloxacin
- Ceftazidime
Incubation Periods - Less than 1 week
Scarlet fever
* Influenza
* Diphtheria
* Meningococcus
Incubation Periods 1 - 2 weeks
Malaria
* Measles
* Dengue fever
* T yphoid
Incubation Periods 3 weeks
- Mumps
- Rubella
- Chickenpox
Incubation Periods Longer than 3 weeks
Infectious mononucleosis
* Cytomegalovirus
* Viral hepatitis
* HIV
Live attenuated vaccines
- BCG
- measles, mumps, rubella (MMR)
- oral polio
- oral typhoid*
- yellow fever
Whole killed organism/inactivated (injectable killed typhoid is no longer used in the UK)
rabies
* influenza
Detoxified exotoxins vaccines
- tetanus
Fragment/Extracts of the organism or virus (may also be produced using recombinant DNA technology)vaccines
diphtheria
* pertussis (‘acellular’ vaccine)
* heptitis B
* meningococcus, pneumococcus, hemophilus
cholera vaccine
contains inactivated Inaba and Ogawa strains of Vibrio cholerae together with recombinant B-subunit of the cholera toxin
hep vaccine
contains HBsAg adsorbed onto aluminium hydroxide adjuvant and is prepared from yeast cells using recombinant DNA technology
Post-Exposure Prophylaxis Hepatitis A
- Human Normal Immunoglobulin (HNIG) or hepatitis A vaccine may be used depending on the clinical situation
ppost-Exposure Prophylaxis Hepatitis b
HBsAg positive source: if the person exposed is a known responder to HBV vaccine then a booster dose should be given. If they are in the process of being vaccinated or are a non- responder they need to have hepatitis B immune globulin (HBIG) and the vaccine
* Unknown source: for known responders the green book advises considering a booster dose of HBV vaccine. For known non-responders HBIG + vaccine should be given whilst those in the process of being vaccinated you have an accelerated course of HBV vaccine
post-Exposure Prophylaxis Hepatitis c
- Monthly PCR - if seroconversion then interferon +/- ribavirin
HIV post-Exposure Prophylaxis
- A combination of oral antiretrovirals (e.g. Tenofovir, emtricitabine, lopinavir and ritonavir) as soon as possible (i.e. Within 1-2 hours, but may be started up to 72 hours following exposure) for 4 weeks
- Serological testing at 12 weeks following completion of post-exposure prophylaxis
- ↓ risk of transmission by 80%
Varicella zoster post-Exposure Prophylaxis
VZIG for IgG negative pregnant women/immunosuppressed
Tetanus vaccine
cell-free purified toxin that is given as part of a combined vaccine (e.g. combined with diphtheria and inactivated polio vaccine)
Tetanus vaccine is currently given in the UK as part of the routine immunisation schedule at:
* 2 months
* 3 months
* 4 months
* 3-5 years
* 13-18 years
Intramuscular human tetanus immunoglobuli
should be given to patients with high-risk wounds (e.g. compound fractures, delayed surgical intervention, significant degree of devitalised tissue) irrespective of whether 5 doses of tetanus vaccine have previously been given
If vaccination history is incomplete or unknown then a dose of tetanus vaccine should be given combined with intramuscular human tetanus immunoglobulin for high-risk wounds
Tetanus is caused by
tetanospasmin exotoxin released from Clostridium tetani. Tetanus spores are present in soil and may be introduced into the body from a wound, which is often unnoticed. Tetanospasmin prevents release of GABA
Tetanus features
- Prodrome fever, lethargy, headache
- Trismus (lockjaw)
- Risus sardonicus
- Opisthotonus (arched back, hyperextended neck)
- Spasms (e.g. Dysphagia)